Literature DB >> 19489448

[Cytotoxicity of antiglaucoma ophthalmic solutions for human corneal endothelial cells].

Masahiko Ayaki1, Yoshiko Noda, Shigeo Yaguchi, Ryohei Koide, Atsuo Iwasawa, Toshu Inoue, Yoichi Inoue.   

Abstract

PURPOSE: The cytotoxicity of a range of commercial antiglaucoma ophthalmic solutions was assessed in human corneal endothelial cells using in vitro techniques.
METHODS: Cell survival was measured using the WST-1 assay for endothelial cells and the MTT assay for epithelial cells. Commercially available timolol, carteolol, latanoplast, unoprostone, levobunolol, bunazosine, betaxolol, nipradiol, dorzolamide, brinzolamide, and pilocarpine were assessed. The survival of cells exposed to test ophthalmic solutions was expressed as a percentage of cell survival in the control solution (distilled water added to media) after 48 hours exposure.
RESULTS: Survival was lower in prostagrandines and in medications containing benzalkonium. It increased to more than 85% after dilution of 1000-fold or more dilution.
CONCLUSIONS: Antiglaucoma ophthalmic solutions have corneal endothelial toxicity. The toxicity significantly decreases after dilution of 1000-fold or more dilution and toxicity seems to be due mostly to benzalkonium chloride.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19489448

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  12 in total

1.  [Glaucoma and corneal transplantation].

Authors:  G Geerling; M Müller; M Zierhut; T Klink
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

2.  Cytotoxic effects of betaxolol on healthy corneal endothelial cells both in vitro and in vivo.

Authors:  Ying Miao; Qian Sun; Qian Wen; Yue Qiu; Yuan Ge; Miao-Miao Yu; Ting-Jun Fan
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

3.  Corneal endothelial changes following a single session of selective laser trabeculoplasty for pseudoexfoliative glaucoma.

Authors:  Nurgül Örnek; Kemal Örnek
Journal:  Int Ophthalmol       Date:  2017-10-13       Impact factor: 2.031

4.  Incidence, severity and factors related to drug-induced keratoepitheliopathy with glaucoma medications.

Authors:  Takeo Fukuchi; Kimiko Wakai; Kieko Suda; Tomoko Nakatsue; Hideko Sawada; Hiroaki Hara; Jun Ueda; Takayuki Tanaka; Akiko Yamada; Haruki Abe
Journal:  Clin Ophthalmol       Date:  2010-04-26

5.  Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells.

Authors:  Masahiko Ayaki; Atsuo Iwasawa; Yoichi Inoue
Journal:  Clin Ophthalmol       Date:  2010-10-21

6.  Changes in corneal parameters at confocal microscopy in treated glaucoma patients.

Authors:  Stefano Ranno; Paolo Fogagnolo; Luca Rossetti; Nicola Orzalesi; Paolo Nucci
Journal:  Clin Ophthalmol       Date:  2011-07-26

7.  Ocular surface disease in posttrabeculectomy/mitomycin C patients.

Authors:  Janice Lam; Tina T Wong; Louis Tong
Journal:  Clin Ophthalmol       Date:  2015-01-29

8.  Risk Factors for Corneal Endothelial Cell Loss in Patients with Pseudoexfoliation Syndrome.

Authors:  Takanori Aoki; Koji Kitazawa; Tsutomu Inatomi; Natsuki Kusada; Noriko Horiuchi; Kazunori Takeda; Norihiko Yokoi; Shigeru Kinoshita; Chie Sotozono
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

9.  Comparison of Cytotoxic Effects on Rabbit Corneal Endothelium between Preservative-free and Preservative-containing Dorzolamide/timolol.

Authors:  Junki Kwon; Jeong Hwa Heo; Hyo Myung Kim; Jong Suk Song
Journal:  Korean J Ophthalmol       Date:  2015-09-22

10.  Dose- and Time-Dependent Cytotoxicity of Carteolol in Corneal Endothelial Cells and the Underlying Mechanisms.

Authors:  Wen Su; Jun Zhao; Ting-Jun Fan
Journal:  Front Pharmacol       Date:  2020-03-06       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.